Damora Therapeutics, Inc. (DMRA) vs Tandem Diabetes Care, Inc. (TNDM)
A side-by-side comparison of Damora Therapeutics, Inc. and Tandem Diabetes Care, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
DMRA
Damora Therapeutics, Inc.
$19.08HealthcareDelayed quote: Oct 6, 2026, 2:19 PM EDT
TNDM
Tandem Diabetes Care, Inc.
$16.25HealthcareDelayed quote: Oct 6, 2026, 2:15 PM EDT
Total return — DMRA vs TNDM
growth of $100 · dividends reinvested · last 6yDMRA -94.6% (-38.5%/yr)TNDM -85.9% (-27.8%/yr)TNDM compounded faster over this window
DMRA TNDM
DMRA vs TNDM: by the numbers
- •DMRA is the larger company ($1.17B vs $1.11B market cap).
- •Both run net losses; DMRA's is the smaller (0.00% vs -6.08% net margin).
Metrics side by side
Valuation
| Metric | DMRA | TNDM |
|---|---|---|
| P/S ratio | N/A | 1.07 |
| P/B ratio | 3.04 | 8.54 |
Profitability
| Metric | DMRA | TNDM |
|---|---|---|
| Gross margin | 0.00% | 56.01% |
| Operating margin | 0.00% | -4.13% |
| Net margin | 0.00% | -6.08% |
| ROE | -50.93% | -48.56% |
| ROIC | -52.44% | -4.77% |
Growth (annualized)
| Metric | DMRA | TNDM |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 11.48% |
| Total return CAGR (5Y) | -25.05% | -32.93% |
Frequently asked
- How have DMRA and TNDM total returns compared?
- Over the past 5 years, DMRA delivered -25.05% and TNDM delivered -32.93% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.